Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo

Institute of Pathobiochemistry and Molecular Neurodegeneration, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research (Impact Factor: 6.59). 02/2013; 28(2). DOI: 10.1002/jbmr.1757
Source: PubMed

ABSTRACT The primary role of apolipoprotein E (apoE) is to mediate the cellular uptake of lipoproteins. However, a new role for apoE as a regulator of bone metabolism in mice has recently been established. In contrast to mice, the human APOE gene is characterized by three common isoforms APOE ε2, ε3 and ε4 that result in different metabolic properties of the apoE isoforms, but it remains controversial whether the APOE polymorphism influences bone traits in humans. To clarify this, we investigated bone phenotypes of apoE knock-in mice, which express one human isoform each (apoE2 k.i., apoE3 k.i., apoE4 k.i.) in place of the mouse apoE. Analysis of 12 week-old female knock-in mice revealed increased levels of biochemical bone formation and resorption markers in apoE2 k.i. animals as compared to apoE3 k.i. and apoE4 k.i., with a reduced OPG/RANKL ratio in apoE2 k.i., indicating increased turnover with prevailing resorption in apoE2 k.i.. Accordingly, histomorphometric and µCT analyses demonstrated significantly lower trabecular bone mass in apoE2 than in apoE3 and apoE4 k.i. animals, which was reflected by a significant reduction of lumbar vertebrae maximum force resistance. Unlike trabecular bone, femoral cortical thickness, and stability was not differentially affected by the apoE isoforms. To extend these observations to the human situation, plasma from middle-aged healthy men homozygous for ε2/ε2, ε3/ε3, and ε4/ε4 (n = 21, n = 80, n = 55 respectively) was analyzed with regard to bone turnover markers. In analogy to apoE2 k.i. mice, a lower OPG/RANKL ratio was observed in the serum of ε2/ε2 carriers as compared to ε3/ε3 and ε4/ε4 individuals (p = 0.02 for ε2/ε2 vs ε4/ε4). In conclusion, the current data strongly underline the general importance of apoE as a regulator of bone metabolism and identifies the APOE ε2 allele as a potential genetic risk factor for low trabecular bone mass and vertebral fractures in humans. © 2012 American Society for Bone and Mineral Research.


Available from: Robert Percy Marshall, Jun 16, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose Although many studies have been performed to evaluate whether or not apolipoprotein E gene (APOE) polymorphisms are differentially associated with bone mineral density (BMD) and fractures, the results have been conflicting. This large-scale study was performed to investigate whether a relationship exists between APOE polymorphisms and risk of fracture. Methods A hospital-based case-control study was conducted in 3,000 patients with fractures and 3,000 age- and gender-matched healthy controls. Polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) assay was applied to assess the APOE gene polymorphisms. Results Patients with fractures had a significantly higher frequency of APOE E2/E2 genotype [odds ratio (OR)=2.02, 95 % confidence interval (CI)=1.30, 3.14; P=0.002] than healthy controls. When stratifying by fracture type, it was found that patients with vertebral fractures had a significantly higher frequency of APOE E2/E2 genotype (OR=2.86, 95 % CI=1.73, 4.73; P < 0.001). No significant differences were found in nonvertebral (hip or wrist or other) fractures. Conclusions Our study suggests that APOE E2/E2 genotype is a potential genetic risk factor for vertebral fractures in humans.
    International Orthopaedics 06/2014; 38(8). DOI:10.1007/s00264-014-2380-4 · 2.02 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The strength of trabecular bone depends on its microarchitecture and its tissue level properties. However, the interrelation between these two determinants of bone quality and their relation to age remains to be clarified. Iliac crest bone cores (n=152) from individuals aged 30-90 years were analyzed by quantitative backscattered electron imaging. Univariate and multivariate analyses were conducted to determine whether epidemiological parameters (age, sex or BMI), structural histomorphometrical variables (BV/TV, Tb.Th, Tb.N and Tb.Sp) and osteoid-related indices (OV/BV, OS/BS or O.Th) predict the degree of bone mineralization. While sex and BMI were not associated with bone mineralization, age was positively correlated with the most frequently occurring calcium concentrations (Ca peak), the percentage of highly mineralized bone areas (Ca high) and, in the case of adjusted co-variates, also the mean calcium content (Ca mean). Bone volume fraction and trabecular thickness were both negatively correlated with Ca mean. However, trabecular thickness was additionally associated with Ca peak, Ca high as well as the amount of low mineralized bone (Ca low) and was the only structural parameter predicting bone mineralization independent of age. Furthermore, our analyses demonstrated that osteoid variables - within a normal range (<2 % OV/BV) - were significantly associated with all mineralization parameters and represent the only predictor for the mineralization heterogeneity (Ca width). Taken together, we showed that elevated trabecular bone mineralization correlates with aging and bone loss. However, these associations are attributable to trabecular thinning that comes along with high bone mineralization due to the loss of low mineralized bone surfaces. Therefore, we demonstrated that the degree of areally resolved bone mineral is primarily associated with the amount of physiological osteoid present and the thickness of mineralized bone in trabeculae.
    Bone 05/2014; DOI:10.1016/j.bone.2014.05.010 · 4.46 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Adequate bony support is the key to reestablish both function and esthetics in the craniofacial region. Autologous bone grafting has been the gold standard for regeneration of problematic large bone defects. However, poor graft availability and donor site complications have led to alternative bone tissue engineering approaches combining osteo-inductive biomaterials and three-dimensional (3D) cell aggregates in scaffolds or constructs. The goal of the present study was to generate novel cell aggregate-loaded macro-porous scaffolds combining the osteo-inductive properties of titanium dioxide (TiO2) with hydroxyapatite-gelatin nanocomposites (HAP-GEL) for regeneration of craniofacial defects. Herein, we investigated the in vivo applicability of macro-porous (TiO2)-enriched HAP-GEL scaffolds with undifferentiated and osteogenically differentiated multipotent adult progenitor cell (MAPC and OD-MAPC, respectively) aggregates for calvaria bone regeneration. The silane coated HAP-GEL with and without TiO2 additives were polymerized and molded to produce macro-porous scaffolds. Aggregates of rat MAPC were pre-cultured, loaded into each scaffold and implanted to rat calvaria critical-size defects (CSD) to study bone regeneration. Bone autografts were used as positive controls and a poly(lactic-co-glycolic acid) (PLGA) scaffold for comparison purposes. Pre-implanted scaffolds and calvaria bone from pig were tested for ultimate compressive strength with an Instron 4411® and for porosity with microcomputerized tomography (µCT). Osteointegration and newly formed bone (NFB) were assessed by µCT and non-decalcified histology, and quantified by calcium fluorescence labeling. Results showed that macro-porous TiO2-HAP-GEL scaffold had a comparable strength relative to natural calvaria bone (13.8±4.5MPa and 24.5±8.3MPa, respectively). Porosity was 1.52±0.8mm and 0.64±0.4mm for TiO2-HAP-GEL and calvaria bone, respectively. At eight and twelve weeks post-implantation into rat calvaria defects, greater osteointegration and NFB was significantly present in the TiO2-enriched HAP-GEL constructs with OD-MAPCs, compared to the undifferentiated MAPC-loaded constructs, cell-free HAP-GEL with and without titanium, and PLGA scaffolds. Tissue-engineered TiO2-enriched HAP-GEL constructs with OD-MAPC aggregates present a potential useful therapeutic approach for calvaria bone regeneration.
    Tissue Engineering Part A 03/2013; 19(15-16). DOI:10.1089/ten.TEA.2012.0520 · 4.64 Impact Factor